ObjectiveProposing hysteroscopic morcellation (HM) as a surgical-therapeutic approach in the treatment of retained products of conception (RPOC) to prevent intrauterine adhesions (IUAs).DesignProspective analysis.SettingA teaching and university hospital.PatientsWomen with RPOC.InterventionsOffice -HM with 'Truclear 5 C'.Material and methodsTwenty-two consecutive patients presenting with trophoblastic residue retention after miscarriage and interruption of pregnancy or placenta remnants after cesarean section or delivery were enrolled. These women underwent office-HM with 'Truclear 5 C'. Primary outcomes were median time and rate of hospitalization. The quality of the specimen was also analyzed. A hysteroscopic second look for IUAs was performed.ResultsMean procedure time was six minutes (SD & PLUSMN; 5). Tissue samples had a mean collection size 2.5 cm(3)+0.9. 38% of the samples had spotting or abnormal vaginal discharge. Dilatation of the cervical canal was not performed in any case. Second-look hysteroscopy did not show any de novo IUAs in any of the enrolled patients.ConclusionsIn the hysteroscopic treatment of RPOC, HM is a valid choice in an office setting without the use of cervical dilatation. Removal of RPOC was uneventful in all cases, simple and carried out faster without any adverse outcomes.
Office intrauterine morcellation for retained products of conception / Damiani, Gianluca Raffaello; Di Gennaro, Daniele; Vimercati, Antonella; Cicinelli, Ettore; Perrone, Anna Myriam; De Iaco, Pierandrea; Malvasi, Antonio; Gaetani, Maria; Cascardi, Eliano; Cazzato, Gerardo; Dellino, Miriam; Pellegrino, Antonio; Vitagliano, Amerigo. - In: MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES. - ISSN 1365-2931. - ELETTRONICO. - 32:6(2023), pp. 323-328. [10.1080/13645706.2023.2227694]
Office intrauterine morcellation for retained products of conception
Perrone, Anna Myriam;De Iaco, Pierandrea;
2023
Abstract
ObjectiveProposing hysteroscopic morcellation (HM) as a surgical-therapeutic approach in the treatment of retained products of conception (RPOC) to prevent intrauterine adhesions (IUAs).DesignProspective analysis.SettingA teaching and university hospital.PatientsWomen with RPOC.InterventionsOffice -HM with 'Truclear 5 C'.Material and methodsTwenty-two consecutive patients presenting with trophoblastic residue retention after miscarriage and interruption of pregnancy or placenta remnants after cesarean section or delivery were enrolled. These women underwent office-HM with 'Truclear 5 C'. Primary outcomes were median time and rate of hospitalization. The quality of the specimen was also analyzed. A hysteroscopic second look for IUAs was performed.ResultsMean procedure time was six minutes (SD & PLUSMN; 5). Tissue samples had a mean collection size 2.5 cm(3)+0.9. 38% of the samples had spotting or abnormal vaginal discharge. Dilatation of the cervical canal was not performed in any case. Second-look hysteroscopy did not show any de novo IUAs in any of the enrolled patients.ConclusionsIn the hysteroscopic treatment of RPOC, HM is a valid choice in an office setting without the use of cervical dilatation. Removal of RPOC was uneventful in all cases, simple and carried out faster without any adverse outcomes.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
